Results 51 to 60 of about 485,856 (155)

Expanding Horizons: Next‐Generation and Interdisciplinary Advances in the Applications of Extracellular Vesicles

Journal of Extracellular Biology, Volume 4, Issue 12, December 2025.
ABSTRACT Extracellular vesicles (EVs) are increasingly recognized as universal mediators of communication in nature across all domains of life and as versatile tools with roles spanning a wide range of industries. Although EVs have been extensively studied in biomedicine, mainly in diagnostic and nanotherapy of cancer and neurodegenerative diseases ...
Esperanza González, Juan Manuel Falcón‐Pérez   +1 more
wiley   +1 more source

MASLD

Revista de la Sociedad Argentina de Diabetes
La enfermedad hepática esteatósica asociada a disfunción metabólica (MASLD) se define actualmente por la presencia de esteatosis hepática (en la gran mayoría de los casos detectada por ecografía) asociada a disfunción metabólica (1 de 5 criterios) sin ...
Adrián Gadano
doaj   +1 more source

Capillaria hepatica-induced septal fibrosis in rats: a contribution to the study of liver fibrogenesis Contribuição para o estudo da fibrogenesis hepática em ratos infectados com Capillaria hepatica

Revista da Sociedade Brasileira de Medicina Tropical, 2010
INTRODUCTION: Septal fibrosis of the liver regularly develops in rats infected with the nematode Capillaria hepatica. Curative treatment of the infection prevents the development of septal fibrosis when intervention occurs up to postinfection day (PID ...
Valter Lucas Chaves Barbosa, Zilton de Araújo Andrade   +1 more
doaj   +1 more source

The Economics of Liver Fibrosis Diagnosis: Systematic Review of Non‐Invasive Test Cost‐Effectiveness

Liver International Communications, Volume 6, Issue 4, December 2025.
ABSTRACT Hepatic diseases progress silently, leading to fibrosis, cirrhosis, and hepatocellular carcinoma. Although liver biopsy remains the gold standard for fibrosis assessment, it is limited by invasiveness and sampling variability. Non‐invasive liver tests (NILTs) can mitigate biopsy‐related risks.
Marilia Mastrocolla de Almeida Cardoso, Fernando Gomes Romeiro, Wendel Mombaque dos Santos, Juliana Machado‐Rugolo, Juliana Tereza Coneglian de Almeida, Lehana Thabane, Kednapa Thavorn, Jean‐Eric Tarride   +7 more
wiley   +1 more source

Pathogenesis of hepatic septal fibrosis associated with Capillaria hepatica infection of rats Patogenia da fibrose septal hepática associada com a infecção por Capillaria hepatica em ratos

Revista da Sociedade Brasileira de Medicina Tropical, 2001
Septal fibrosis is a common form of hepatic fibrosis, but its etiology and pathogenesis are poorly understood. Rats infected with the helminth Capillaria hepatica constitute a good experimental model of such fibrosis.
Antônio Benigno dos Santos, Miguel Tolentino Junior, Zilton A. Andrade   +2 more
doaj   +1 more source

Marked Variation in Hepatic Steatosis in Metabolic Dysfunction‐Associated Steatotic Liver Disease Over 5 Years: A Community‐Based Study Using Controlled Attenuation Parameter

United European Gastroenterology Journal, Volume 13, Issue 10, Page 1946-1954, December 2025.
ABSTRACT Background Metabolic dysfunction‐associated steatotic liver disease (MASLD) is very common and associated with significant morbidity and mortality due to its potential progression to cirrhosis and liver cancer. Whereas hepatic fat accumulation is the key to MASLD progression, little is known regarding changes in liver fat content over time in ...
Marta Cervera, Martina Pérez‐Guasch, Marta Carol, Ruth Nadal, Maria Sanz‐Rodríguez, Adrià Juanola, Anna Soria, Rosario Hernández, Gemma Saez, Míriam Pellón, Queralt Herms, Elisa Pose, Pere Ginès, Isabel Graupera, Núria Fabrellas   +14 more
wiley   +1 more source

Estudio sobre la sobrecarga de hierro en pacientes con hepatitis C crónica

Acta Gastroenterológica Latinoamericana, 2013
Introducción. La hepatitis C es una enfermedad crónica con distribución mundial. Diferentes factores han sido asociados con una progresión más rápida hacia la fibrosis y la cirrosis hepática tales como el consumo de alcohol mayor de 30 g/día, la edad ...
Ednaldo Andrade Bomfim, Andrea Cristina Pereira de Oliveira, Raymundo Paraná, María Isabel Schinoni   +3 more
doaj  

Rendimiento diagnóstico del FibroScan en un centro de enfermedades hepáticas en Bogotá durante el 2019 al 2022

Revista Colombiana de Gastroenterología
Introducción: en el proceso diagnóstico de las enfermedades hepáticas, la historia clínica y el perfil bioquímico hepático son fundamentales. La biopsia hepática es el parámetro de referencia para el diagnóstico, evaluación de la actividad, estado de ...
Diana del Pilar Torres Pabón, Benedicto Velasco, Jonathan Alexander Guezguan Pérez   +2 more
doaj   +1 more source

Elevated Serum Bile Acids Predict Poor Liver Outcomes in Children With Alagille Syndrome: Results From the GALA Study Group

Liver International, Volume 45, Issue 12, December 2025.
ABSTRACT Background and Aim Alagille syndrome (ALGS) is a rare disorder characterised by cholestasis and extrahepatic manifestations. Given the current era of ileal bile acid transporter (IBAT) inhibitor therapies that reduce serum bile acid (SBA) levels, we evaluated whether SBA predicts liver disease outcomes in ALGS.
Carla Fiorella Murillo Perez, Shannon M. Vandriel, Emmanuel M. Gonzales, Jian‐She Wang, Li‐Ting Li, Huiyu She, Irena Jankowska, Piotr Czubkowski, Dorota Gliwicz‐Miedzińska, Emmanuel Jacquemin, Jérôme Bouligand, Lorenzo D'Antiga, Emanuele Nicastro, Björn Fischler, Henrik Arnell, Susan M. Siew, Michael Stormon, Kathleen M. Loomes, David A. Piccoli, Elizabeth B. Rand, James E. Squires, Saul J. Karpen, Rene Romero, Mureo Kasahara, Zerrin Önal, Étienne Sokal, Tanguy Demaret, Sabina Wiecek, Florence Lacaille, Dominique Debray, Winita Hardikar, Sahana Shankar, Pamela L. Valentino, Shikha S. Sundaram, Noelle H. Ebel, Jeffrey A. Feinstein, Orith Waisbourd‐Zinman, Henry C. Lin, Nathalie Rock, Henkjan J. Verkade, M. Kyle Jensen, Catalina Jaramillo, Kyung Mo Kim, Seak Hee Oh, Jernej Brecemiclj, Seema Alam, Giuseppe Indolfi, Niviann Blondet, Rima Fawaz, Silvia Nastasio, Pier Luigi Calvo, Gabriella Nebbia, Cigdem Arikan, Catherine Larson‐Nath, Andréanne N. Zizzo, Thomas Damgaard Sandahl, Christos Tzivinikos, Nehal M. El‐Koofy, Mohamed A. Elmonem, Amal A. Aqul, Wikrom Karnsakul, Pinar Bulut, Nanda Kerkar, Victorien M. Wolters, Amin J. Roberts, Helen M. Evans, Maria Camila Sanchez, Maria Lorena Cavalieri, Deirdre A. Kelly, Jane Hartley, Way Seah Lee, Christina Hajinicolaou, Chatmanee Lertudomphonwanit, Ryan T. Fischer, Jesus Quintero Bernabeu, Ruben E. Quiros‐Tejeira, Cristina Targa Ferreira, Elisa Carvalho, John Eshun, Aglaia Zellos, Antal Dezsőfi, Raquel Borges Pinto, Kathleen Schwarz, Maria Rogalidou, Jennifer Garcia, María Legarda Tamara, Marisa Beretta, Quais Mujawar, Ermelinda Santos‐Silva, Cristina Molera Busoms, Eberhard Lurz, Cristina Gonçalves, Carolina Jimenez‐Rivera, Jesus M. Banales, Richard J. Thompson, Bettina E. Hansen, Binita M. Kamath, The Global ALagille Alliance (GALA) Study Group   +97 more
wiley   +1 more source

Report on the 2nd MObility for Vesicle research in Europe (MOVE) symposium—2024

FEBS Open Bio, Volume 15, Issue 11, Page 1726-1737, November 2025.
The 2nd MObility for Vesicle research in Europe (MOVE) Symposium in Belgrade brought over 280 attendees from 28 countries to advance extracellular vesicle (EV) research. Featuring keynotes, presentations, and industry sessions, it covered EV biogenesis, biomarkers, therapies, and manufacturing.
Dorival Mendes Rodrigues‐Junior, Michaela Kocholata, Marilena E. Lekka, Olga Janouskova, Moran Yadid, Maja Kosanovic   +5 more
wiley   +1 more source